Cargando…
sFgl2 gene-modified MSCs regulate the differentiation of CD4(+) T cells in the treatment of autoimmune hepatitis
BACKGROUND: Autoimmune hepatitis (AIH) is a T-cell-mediated autoimmune liver disease that can lead to liver injury and has a poor long-term prognosis. Mesenchymal stromal cells (MSCs) have immunosuppressive effects and can treat AIH. CD4(+) T cells express the unique inhibitory Fcγ receptor (FcγRIIB...
Autores principales: | Ji, Wenbin, Wang, Weiwei, Li, Peiyuan, Liu, Yanhong, Zhang, Baotong, Qi, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625288/ https://www.ncbi.nlm.nih.gov/pubmed/37924141 http://dx.doi.org/10.1186/s13287-023-03550-x |
Ejemplares similares
-
Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation
por: Gao, Chao, et al.
Publicado: (2020) -
sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
por: An, Tianhui, et al.
Publicado: (2023) -
Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016) -
Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu
por: Hou, Xin-Xin, et al.
Publicado: (2021) -
Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2
por: Fu, Yong, et al.
Publicado: (2020)